The New Drug Basket: 1Q 2025 FDA Approvals

At Prodigy, we keep a close eye on the FDA’s basket of newly approved drugs—tracking every fresh hatch, whether or not it’s immediately relevant to workers’ comp. Our pipeline report is packed with insights on novel therapies that could crack into your claims down the road, whether on-label or off.

By staying ahead of the curve, claims professionals can make smarter decisions and deliver better care—no guesswork, just well-informed strategy.